3. Parenteral nutrition
• Definition:
Pharmacological therapies where nutrients,
vitamins, electrolytes and medications are
delivered via venous route to those
patients whose GIT is not functioning and
are unable to tolerate enteral nutrition.
▪
4. Indications
1. When patient gastrointestinal tract is paralysed and nonfunctional, as in the case of complete bowel obstruction, bowel ischemia,
ileus,
2. Circulatory shock with high-dose vasopressor requirements
3. When >7 days of nothing-by-mouth (NPO) status is anticipated, as in the case of inflammatory bowel disease, patients with an
acute exacerbation, critically ill patients and so on
4. When the baby’s gut is too immature or has congenital malformations
5. When the patient is suffering from chronic diarrhoea and vomiting or is extremely undernourished and needs to have surgery,
chemotherapy and so on
6. When patients with bowel anastomoses develop anastomotic leaks in the early postoperative period
• Nevertheless, the aim in all patients fed intravenously should be to revert to enteral feeding as this becomes possible.
WHO?
5. • Parenteral feeding solutions may be prepared from
their component parts under sterile conditions.
• ▪ Readymade solutions also exist, but any necessary
additions must be made in the same way.
• ▪ In ICU patients the daily requirements are infused
continuously over 24 hours. Careful biochemical and
clinical monitoring is important, particularly at the
outset
HOW?
6. Access
• Solutions for peripheral parenteral nutrition are hypertonic to blood, and
their osmolality should not exceed 900 mOsm/L.
• osmolality > 900 mOsm/L, the incidence of phlebitis inflammation, and pain
• Adding 5000 units of heparin to a peripheral parenteral nutrition solution may
prolong the duration of the peripheral line.
• The major concern with central venous access for TPN is prevention of infection.
• Subclavian lines have lower infection rates than internal jugular or femoral lines.
• Tunnelling may reduce infection rates in internal jugular lines but apparently not
in short-term subclavian lines. It is not recommended for routine use.
• a multi-lumen catheter is used, one lumen should be dedicated to administration
of TPN and not used for any other purpose. Three-way taps should be avoided
and infusion set changes carried out daily under sterile conditions
Central venous catheter
PICC
Peripheral line
7. • Peripherally inserted catheters are inserted through a peripheral, usually antecubital, vein and then
advanced into a central vein.
• They can be placed if the intended duration of parenteral nutrition is more than 2 weeks, and they
can be used for up to 6 months in stable patients.
• Advantage: avoidance of the risks associated with the puncture of a central vein.
• Disadvantage: lead to a higher rate of phlebitis.
8. • Peripheral (partial or supplemental) parenteral nutrition:
– Minimizes cost and complications of the central catheter
– Can provide supplemental calories and protein not met by enteral route
– Phlebitis, requires frequent site rotations and fluid overload
9. SUBSTRATE SOLUTIONS
• Dextrose Solutions
• Standard nutrition support regimens use carbohydrates to supply approximately 70% of the daily
(nonprotein) caloric requirements. The carbohydrate source for total parenteral nutrition (TPN) is
dextrose (glucose), which is available as solutions.
• Hyperosmolar must be infused through large central veins
D50
10. • Amino Acid Solutions
• Protein is provided as amino acid solutions that contain varying mixtures of essential
(N=9), semi-essential (N=4), and nonessential (N=10) amino acids.
• These solutions are mixed with dextrose solutions in a 1:1 volume ratio.
• Standard Solutions: (e.g., Aminosyn)
• balanced mixtures of 50% essential amino acids and 50% nonessential and semi-essential amino acids.
• Available concentrations range- 3.5%, 5%, 7%, 8.5%, 10%, but 7% solutions (70 g/L) are used most
often.
Glutamine, tyrosine and cysteine are absent from many because of instability
11. • Specialty Solutions
1. Metabolic stress (e.g., Aminosyn-HBC ) are enriched with branched chain amino acids (iso-leucine, leucine,
and valine), which are preferred fuels in skeletal muscle when metabolic demands are high.
2. Renal failure solutions (e.g., Aminosyn RF) are rich in essential amino acids, because the nitrogen in essential
amino acids is partially recycled to produce nonessential amino acids, which results in smaller increments in
blood urea nitrogen (BUN) when compared with breakdown of nonessential amino acids.
3. Hepatic failure (e.g., HepaticAid) are en-riched with branched chain amino acids, which block the transport of
aromatic amino acids across the bloodbrain barrier (which is implicated in hepatic encephalopathy).
.
12. • Lipid Emulsions
• Lipids are provided as emulsions composed of submicron droplets of cholesterol, phospholipids, and
triglycerides.
• The triglycerides are derived from vegetable oils (safflower or soybean oils) and are rich in linoleic acid,
an essential fatty acid.
• 30% of daily caloric requirements, and 4% of the daily calories should be provided as linoleic acid to
prevent essential fatty acid deficiency.
• Available in 10% and 20% strengths (the percentage refers to grams of triglyceride per 100 mL of
solution).
• 10% emulsions 1 kcal/mL.
• 20% emulsions 2 kcal/mL.
• Isotonic to plasma and can be infused through peripheral veins.
• The lipid emulsions are available in unit volumes of 50 to 500 mL, and can be infused separately (at a
maximum rate of 50 mL/hour) or added to the dextrose–amino acid mixtures.
13. • ▪ Intralipid with PN is controversial because past studies have shown that long-chain fats can cause
immune suppression. It can promote dysfunction of the reticuloendothelial system, enhance
formation of prostanoids and leukotrienes, increase generation of ROS, and adversely affect the
composition of cell membranes.
• ▪ Among trauma patients, the use of PN without lipids versus with lipids was associated with a
significant reduction in pneumonia (48% versus 73%; P=0.05), catheter-related sepsis (19%
versus 43%; P=0.04), length of ICU stay (18 versus 29 days; P=0.02), and length of hospital
stay (27 versus 39 days; P=0.03).
• ▪ However, some fat—at least 5% of total calories—has to be provided as lipid emulsion to prevent
essential fatty acid deficiency, although this issue is usually not important until after the first 10 days
of hospitalization.
14. • Vitamin and trace element preparations are added to TPN solutions in appropriate amounts.
Thiamine, folic acid and vitamin K are particularly vulnerable to depletion and additional doses may
be necessary.
.
15.
16.
17. Parenteral Nutrition Delivery
1. as separate solutions for carbohydrates, amino acids, and
lipids;
2. as a primary amino acid and glucose solution (two-in-one)
with the lipid component as piggyback;
3. as a three-in-one admixture (all-in-one infusion).
18.
19. CREATING A TPN REGIMEN
• Step 1
• The first step is to determine the daily requirement for calories and protein.
• The daily requirement for calories is 25 kcal/kg, and the daily protein requirement is 1.2–1.6 g/kg.
• For the 70 kg patient, we’ll use actual body weight, and a daily protein requirement of 1.4 g/kg.
Therefore, the daily requirement for calories and protein will be:
20. • Step 2
• Take a standard mixture of 10% amino acids (500 mL) and 50% dextrose (500 mL) and determine
the volume of this mixture that is needed to deliver the estimated daily protein requirement.
• Final A10-D50 mixture ====> 5% amino acids (50 grams of protein per liter) and 25% dextrose
(250 grams of dextrose per liter)
• The volume of the that will provide the daily protein requirement
• Rate-
21. • Step 3
• Determine how much dextrose is in 1.9 liters of A10-D50:
22. • Step 4
• The next step is to use lipid calories to make up the difference between the calories supplied by
dextrose and the daily requirement for calories.
will be provided by lipids.
If a 10% lipid emulsion (1 kcal/mL) is used, the volume will be 135 mL/day.
23. • Step 5
The TPN orders for this example can be written as follows:
1. A10-D50 to run at 80 mL/hour.
2. 10% Intralipid, 150 mL, to infuse over 3 hours.
3. Add standard electrolytes, multivitamins, and trace elements.
TPN orders are rewritten each day.
Specific electrolytes, vitamins, and trace elements are added to the daily orders when needed
24. Calculation of daily requirement
• ▪ Sample calculation for 60 kg, stable, euvolemic patient with good urine output and moderate
stress
• ▪ Fluid requirement: 35ml/kg = 2100 ml/day
• ▪ Calories: 25kcal/kg = 1500 kcal/day
• ▪ Proteins: 1g/kg = 60 g/day = 240 kcal/day (4kcal/g)
• ▪ Fats: 30% of total calories = 450 kcal/day = 50g fat(9kcal/g)
• ▪ Carbohydrates: 1500 – (240+450) = 810kcal = 202.5g of dextrose (4kcal/g)
25. Convert requirements into
prescription
• Fluid volume reqd. = Amt. of substance(gm) X 100 Conc. Of substance(%)
• Determine volume of lipid emulsion: 10% lipid emulsion
• Volume of lipid emulsion = 50/10 x 100 = 500 ml
• Determine volume of amino acid infusion: 10 % solution
• Volume of amino acids = 60/10 X 100 = 600 ml
26. • Selection of dextrose infusion: in remaining 1000 ml volume,
• 202.5g dextrose needs to be infused.
• 1000 = 202.5 X 100 Conc. of subst.
• ▪ Concentration of substance = 202.5/1000 X 100 = 20.25% = 20% approx.
• ▪ Prescription: Pt. needs
• 500ml of 10% lipid emulsion
• 600ml of 10% amino acid and
• 1000 ml of 20% dextrose
27. Termination of parenteral nutrition
• ▪ Goal: restart oral/enteral food intake as soon as GI function improves.
• ▪ Gradual transition from PN to oral/enteral nutrition.
• ▪ Reduce infusion rate to 50% for 1-2 hrs before stopping PN (minimizes risk of rebound
hypoglycemia).
• ▪ When 60% of total energy and protein requirements are taken orally/enterally, PN may be
stopped.
• ▪ Oral or iv electrolytes supplementation may be needed.
29. PERIPHERAL PARENTERAL NUTRITION
• Peripheral parenteral nutrition (PPN) is a truncated form of TPN that can be used to provide nonprotein calories in amounts that
will spare the breakdown of proteins to provide energy (i.e., protein-sparing nutrition support).
• Peripheral parenteral nutrition (PPN) is meant to act as a supplement and is used when the patient has another source of
nutrition.
• Uses
• as a supplement to enteral feeding
• as a source of calories during brief periods of inadequate nutrition.
• Not intended for hypercatabolic or malnourished patients, who need full nutritional support
• The osmolarity of peripheral vein infusates should be kept below 900 mosm/L, with a pH between 7.2 and 7.4, to slow the rate
of osmotic damage to vessels. This requires dilute amino acid and dextrose solutions, which limits nutrient intake.
• Lipids (isotonic) can be used to provide a considerable portion of the nonprotein calories in PPN.
• A mixture of 3% amino acids and 20% dextrose (final concentration of 1.5% amino acids and 10% dextrose), which has an
osmolarity of 500 mosm/L.
31. • Step 1: Initial resuscitation
• Nutrition should be started as soon as the patient is resuscitated.
• Step 2: Assess nutritional status
• (A) History
• 1. Weight change
• 2. Dietary intake change relative to normal
• 3. Gastrointestinal symptoms (persisting for more than 2 weeks)
• 4. Functional capacity
• 5. Disease and its relationship to nutritional requirements
• (B) Physical examination
• Loss of subcutaneous fat (triceps, chest)
• Muscle wasting (quadriceps, deltoids)
• Ankle edema/sacral edema/ascites
• (C) Subjective global assessment rating
• Well nourished
• Moderately malnourished
• Severely malnourished
32. • Step 3: Calculate ideal (predicted) body weight
• Step 4: Estimate energy (calories) requirement
• Rule of the “thumb”: 25–30 kcal/kg IBW meets most patients’ needs.
• In undernourished patients, initial calorie should be 25% less than IBW to prevent refeeding, and in overweight patients, initial
calorie should be 25% more than IBW to meet requirement.
• Step 5: Estimate protein (nitrogen) requirement
• Rule of the “thumb”: 1.5–2 g of protein/kg IBW meets most patients’ needs
• 6.25 g of protein is equal to 1 g of nitrogen.
• Step 6: Supplement micronutrients
• Step 7: Estimate fluid and electrolyte requirement
• Step 8: Select route of delivering nutrition
• Step 9: Select the type of enteral feed - Blenderized diets/ Polymeric diets/ Predigested diets/ Disease-
specific diets/ Immunonutrition
• Step 10: Look for tolerance to enteral feed
• Step 11: Select candidates for parenteral nutrition
• Step 12: Select the route of total parenteral nutrition (TPN)
• Step 13: Monitor patients on parenteral nutrition
• Step 14: Look for complications of TPN